Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A small molecule oral agonist of the human glucagon-like peptide-1 receptor
Set up a weight loss consult to see which one is best for you
Richard Siegel, co-director of the Diabetes and Lipid Center at Tufts Medical Center in Boston
DNA Repair & Epigenetic Modulation GHK-Cu influences gene expression linked to cellular repair, immune function, and anti-aging pathways
Metformin-induced regulation of the intestinal D-glucose transporters
Qualifying Comorbidities FDA labeling and clinical guidelines commonly recognize: Hypertension (blood pressure 130/80 or taking antihypertensive medication) Type 2 diabetes (HbA1c 6.5% or on glucose-lowering medication) Prediabetes (HbA1c 5.7-6.4% or impaired fasting glucose) Dyslipidemia (elevated LDL, low HDL, or elevated triglycerides) Obstructive sleep apnea (diagnosed via sleep study) Cardiovascular disease (prior MI, stroke, coronary artery disease) Non-alcoholic fatty liver disease / MASLD Polycystic ovary syndrome (PCOS) with metabolic features Osteoarthritis weight-bearing joints Insurance formularies may be stricter some require objective documentation (lab values, sleep study reports) rather than self-report
